60 day FRN

4990

Federal Register / Vol. 85, No. 18 / Tuesday, January 28, 2020 / Notices

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–01387 Filed 1–27–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–0278; Docket No. CDC–2020–
0004]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled the National Hospital Ambulatory
Medical Care Survey (NHAMCS).
NHAMCS collects facility and visit
information on ambulatory care services
utilization in non-Federal, short stay
hospitals in the United States.
DATES: CDC must receive written
comments on or before March 30, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0004 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the

jbell on DSKJLSW7X2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

17:02 Jan 27, 2020

Jkt 250001

proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Hospital Ambulatory
Medical Care Survey (NHAMCS) (OMB
Control No. 0920–0278, Exp. 06/30/
2021)—Revision—National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on ‘‘utilization of health care’’
in the United States. The National
Hospital Ambulatory Medical Care
Survey (NHAMCS) has been conducted
annually since 1992. NCHS is seeking
OMB approval to extend this survey for
an additional three years.
The target universe of the NHAMCS is
in-person visits made to emergency
departments (EDs) of non-Federal, shortstay hospitals (hospitals with an average
length of stay of less than 30 days) that
have at least 6 beds for inpatient use,
and with a specialty of general (medical
or surgical) or children’s general.
NHAMCS was initiated to
complement the National Ambulatory
Medical Care Survey (NAMCS, OMB
No. 0920–0234, Exp. Date 05/31/2022),
which provides similar data concerning
patient visits to physicians’ offices.
NAMCS and NHAMCS are the principal
sources of data on ambulatory care
provided in the United States. NHAMCS
provides a range of baseline data on the
characteristics of the users and
providers of hospital ambulatory
medical care. Data collected include
patients’ demographic characteristics,
reason(s) for visit, providers’ diagnoses,
diagnostic services, medications, and
disposition. These data, together with
trend data, may be used to monitor the
effects of change in the health care
system, for the planning of health
services, improving medical education,
determining health care work force
needs, and assessing the health status of
the population.
Starting 2018, NHAMCS was
modified to assess only hospital
emergency departments. The survey
components that assessed hospital
outpatient departments and ambulatory
surgery locations were discontinued. No
substantive changes or supplements are
expected for the survey for the three
years being requested.
Users of NHAMCS data include, but
are not limited to, congressional offices,
Federal agencies, state and local
governments, schools of public health,
colleges and universities, private
industry, nonprofit foundations,
professional associations, clinicians,
researchers, administrators, and health
planners. There are no costs to the
respondents other than their time. The
total estimated annualized burden hours
are 1,124.

E:\FR\FM\28JAN1.SGM

28JAN1

4991

Federal Register / Vol. 85, No. 18 / Tuesday, January 28, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Hospital Chief Executive Officer .......
Ancillary Service Executive ...............
Medical Record Clerk .......................

Hospital Induction Data Collection ...
Ambulatory Unit Induction (ED only)
Retrieving Patient Records (ED
only).
Reabstraction Telephone interview
(ED only).

410
820
410

1
1
100

30/60
15/60
1/60

205
205
683

125

1

15/60

31

...........................................................

........................

........................

........................

1,124

Ancillary Service
interview.

Executive—Re-

Total ...........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–01383 Filed 1–27–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1158]

Agency Forms Undergoing Paperwork
Reduction Act Review

jbell on DSKJLSW7X2PROD with NOTICES

Number of
responses
per
respondent

Number of
respondents

Type of respondents

In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled, ‘‘CDC Ideation
Catalyst (I-Catalyst) Program and
Customer Engagement Information
Collection’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on October
25, 2019 to obtain comments from the
public and affected agencies. CDC
received one comment. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

VerDate Sep<11>2014

17:02 Jan 27, 2020

Jkt 250001

(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
CDC Ideation Catalyst (I-Catalyst)
Program and Customer Engagement
Information Collection (OMB Control
No. 0920–1158, Exp. 1/31/2020)—
Revision—Office of Science, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC Office of Technology and
Innovation (OTI), located within CDC’s
Office of Science (OS), fosters
innovative science and promotes the
testing and implementation of
innovative ideas that improve CDC’s
ability to have public health impact. To
arm CDC staff with an expanded skillset and tools to evaluate and translate
their insights and ideas into solutions,
CDC developed an experiential
innovation curriculum and consultation
service called Ideation Catalyst (ICatalyst). The program was created with
the belief that innovation should be
customer-driven, based on user

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

research, and enhanced by the
engagement of people at all levels of an
organization. CDC also obtained OMB
approval for a generic clearance to
support the collection of information
from stakeholders and customers,
utilizing I-Catalyst program principles
and methodology (CDC I-Catalyst
Program, OMB No. 0920–1158, exp. date
1/31/2020).
The goal of the I-Catalyst program and
service is to help CDC explore, develop,
and test new approaches to solving
public health problems through a
discovery, ideation, and prototyping
process. I-Catalyst offers a process for
defining problems and engaging
stakeholders that improves the quality,
efficiency, and performance of
innovative solutions. Through the ICatalyst process, teams of CDC program
representatives, in consultation with
OTI, work with stakeholders to define
and articulate a problem and to identify
potentially effective solutions.
Participating teams go through a
hypothesis-testing, scientific method of
discovery to gather important insights
and identify technical or contextual
issues associated with defining a
problem or implementing a solution.
Teams are forced ‘‘out of the classroom’’
to conduct interviews, study customer/
stakeholder needs, collect feedback, and
find partnership opportunities. Only
conversations with potential customers/
stakeholders can provide the facts from
which hypotheses are proven or
disproven about whether a solution (i.e.,
a product, process, etc.) creates value for
the intended customer/stakeholder.
CDC estimates that an average of 10–
20 project teams will participate in the
I-Catalyst process per year. On average,
each team will collect information from
approximately 25 customers/
stakeholders (a total of 500 respondents
per year). Information will be collected
primarily through on-site, unstructured
interviews with individuals who
represent the customers or stakeholders
CDC teams are attempting to serve or
benefit. CDC may also collect

E:\FR\FM\28JAN1.SGM

28JAN1